Bhatara VS, Magnus RD, Paul KL, et al. Serotonin syndrome induced by
venlafaxine and fluoxetine: a case study in polypharmacy and potential
pharmacodynamic and pharmacokinetic mechansims. Ann Pharmacother.
1998;32(4):432-436.
Bodner RA,Lynch T, Lewis L, Kahn D. Serotonin syndrome. Neurol.
1995;45(2):219-223.
Diamond S, Pepper BJ, Diamond MI, et al. Serotonin syndrome induced by
transitioning from phenelzine to venlafaxine: four patient reports.
Neurol. 1998;51(1):274-276.
Elko CJ, Burgess JL, Robertson WO. Zolpidem--associated hallucinations and
serotonin reuptake inhibition: a possible interaction. J Toxicol Clin
Toxicol. 1998;36(3):195-203.
Gardner DM, Lynd LD. Sumatriptan contraindications and the serotonin
syndrome. Ann Pharmacother. 1998;32(1):33-38.
George TP, Godleski LS. Possible serotonin syndrome with trazodone addition
to fluoxetine. Biol Psychiatry. 1996 Mar;39(5):384-385.
Hernandez AF, Montero MN, Pla A, Villanueva E, et al. Fatal moclobemide
overdose or death caused by serotonin syndrome? J Forensic Sci.
1995;40(1):128-130.
Hines Burnham, et al, eds. Drug Facts and Comparisons 2000. 55th ed.
St. Louis, MO:Facts and Comparisons; 2000.
Joffe RT, Sokolov ST. Co-adminstration of fluoxetine and sumatriptan: the
Canadian experience. Acta Psychiatr Scand. 1997;95(6):551-552.
Joly P, Lampert A, Thomine E, Lauret P. Development of pseudobullous morphea
and sclero-derma-like illness during therapy with L-5-hydroxytryptophan and
carbidopa. J Am Acad Dermatol. 1991;25(2):332-333.
Mason BJ, Blackburn KH. Possible serotonin syndrome associated with tramadol
and sertraline coadministration. Ann Pharmacother.
1997;31(2):175-177.
Nisijima K, Shimizu M, Abe T, Ishijuro T. A case of serotonin syndrome
induced by concomitant treatment with low-dose trazodone and amitriptyline and
lithium. Int Clin Psychopharmacol. 1996 Dec;11(4):289-290.
Perry NK. Venlafaxine-induced serotonin syndrome with relapse following
amitripyline. Postgrad Med J. 2000;76(894):254.
Reeves RR, Bullen JA. Serotonin syndrome produced by paroxetine and low-dose
trazodone. Psychosom. 1995 Mar-Apr;36(2):159-160.
Spiller HA, Gorman SE, Villalobos D, et al. Prospective multicenter
evaluation of tramadol exposure. J Toxicol Clin Toxicol.
1997;35(4):361-364.
Sternberg EM, Van Woert MH, Young SN, et al. Development of a
scleroderma-like illness during therapy with L-5-hydroxytryptophan and
carbidopa. New Eng J Med. 1980;303:782-787.
Toner LC, Tsambiras BM, Catalano G, et al. Central nervous system side
effects associated with zolpidem treatment. Clin Neuropharmacol.
2000;23(1):54-58.